IFU labeling artefact for Fabrizyme-β in Germany. Version 19.3. Language: fr.

Artifact ID
LBL-040
Type
IFU
Market
Germany
Version
19.3
Language
fr
Status
In Progress
Last Reviewed
2024-04-08
Included Statements (6)
IDTypeSourceTextApproved
STMT-118EfficacySmPC Section 4.8The medicinal product should not be used during pregnancy unless clearly necessa…2022-11-22
STMT-119ContraindicationSmPC Section 5.1This medicinal product is contraindicated in patients with known hypersensitivit…2024-05-18
STMT-120PKSmPC Section 4.1Patients should be advised not to drive or operate machinery if they experience …2023-06-19
STMT-121SafetySmPC Section 4.1No dose adjustment is required in patients with mild to moderate hepatic impairm…2024-02-19
STMT-122InteractionSmPC Section 4.5Renal impairment does not significantly alter the pharmacokinetics of this compo…2024-06-14
STMT-123PKSmPC Section 4.2Drug interactions with strong CYP3A4 inhibitors may increase exposure by up to 3…2022-11-03
Change History
2023-10-10 · James O'Brien
Interaction section update